Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome

Homozygous carriers of factor V Leiden (FVL) have an up to 80-fold increased risk of venous thrombosis, but the risk of obstetric complications in FVL homozygosity is unclear. To compare obstetric and thromboembolic complications among factor V Leiden (FVL) homozygous and heterozygous carriers treat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Israel Medical Association journal 2014-02, Vol.16 (2), p.96-100
Hauptverfasser:	Gat, Itai, Dulitzki, Mordechai, Schiff, Eyal, Sivan, Eyal, Simchen, Michal J
Format:	Artikel
Sprache:	eng
Schlagworte:	Abruptio Placentae - epidemiology Abruptio Placentae - etiology Adult Anticoagulants - administration & dosage Case-Control Studies Chemoprevention - methods Factor V - genetics Female Fetal Growth Retardation - epidemiology Fetal Growth Retardation - etiology Genetic Carrier Screening Heparin, Low-Molecular-Weight - administration & dosage Heterozygote Homozygote Humans Israel - epidemiology Peripartum Period Pre-Eclampsia - epidemiology Pre-Eclampsia - etiology Pregnancy Pregnancy Outcome Retrospective Studies Thrombophilia - complications Thrombophilia - epidemiology Thrombophilia - genetics Thrombophilia - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!